Westphal, Theresa
Gampenrieder, Simon Peter
Greil, Richard
Funding for this research was provided by:
Paracelsus Medical University
Article History
Received: 16 May 2019
Accepted: 25 July 2019
First Online: 15 August 2019
Conflict of interest
: Theresa Westphal: Speakers Honoraria: Novartis; Travel grants: Roche, Pfizer. Simon Peter Gampenrieder: Speakers Honoraria: Novartis, Roche, AstraZeneca; Advisory Boards: Roche, Novartis, Pfizer, AstraZeneca; Travel grants: Roche, Novartis, Pfizer; Research funding: Roche. Richard Greil: Speakers Honoraria: Novartis, Roche, AstraZeneca; Advisory Boards: Roche, Novartis, AstraZeneca; Travel grants: Roche, Novartis, AstraZeneca; Research funding: Novartis, Roche, AstraZeneca